Galderma Group AG (GALD.SW)

Switzerland · Healthcare · CHF

Key financials

ROE: 7.69%; 2025 (actual)
ROA: 4.71%; 2025 (actual)
Gross Margin: 68.86%; 2025 (actual)
Net Margin: 11.7%; 2025 (actual)
Total Assets: CHF 13,393.00M; 2025 (actual)
Net Income: CHF 613.00M; 2025 (actual)
Valuation: CHF 37,717.61M; 2025 (actual)
Stock Price: CHF 161.75; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	7.69%	7.73%	8.65%	9.25%	9.47%	9.32%
Sector average	-19.57%	-18.86%	21.26%	45.9%	27.83%	13.61%
ROA	4.71%	4.73%	5.33%	5.73%	5.94%	5.94%
Sector average	-4.19%	-6.68%	-24.58%	1.77%	-29.44%	7.73%
Gross Margin	68.86%	68.86%	68.86%	68.86%

Amounts in CHF (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Galderma Group AG? It covers the balance sheet, income statement and Equlion model projections.

Total Assets	CHF 13,393.00M	CHF 14,330.16M	CHF 15,566.60M	CHF 16,928.81M	CHF 18,357.94M	CHF 19,757.58M
Sector average	CHF 6,583.66M	CHF 7,029.78M	CHF 7,875.11M	CHF 8,842.33M	CHF 9,880.55M	CHF 10,888.36M

Net Income	CHF 613.00M	CHF 655.75M	CHF 796.49M	CHF 931.47M	CHF 1,047.63M	CHF 1,132.58M
Sector average	CHF 509.04M	CHF 497.74M	CHF 567.21M	CHF 655.95M	CHF 738.04M	CHF 795.14M

Valuation	CHF 37,717.61M	CHF 38,467.22M	CHF 39,195.76M	CHF 39,905.86M	CHF 40,604.50M	CHF 41,302.83M
Sector average	CHF 12,182.57M	CHF 13,169.96M	CHF 13,319.59M	CHF 13,502.66M	CHF 13,728.88M	CHF 13,908.08M

Stock Price	CHF 161.75	CHF 164.96	CHF 168.09	CHF 171.13	CHF 174.13	CHF 177.12
Sector average	CHF 102.74	CHF 98.77	CHF 102.59	CHF 107.21	CHF 112.19	CHF 115.32